Timing of antiretroviral therapy for HIV-1 infection and tuberculosis Academic Article uri icon

Overview

MeSH Major

  • AIDS-Related Opportunistic Infections
  • Anti-Retroviral Agents
  • Antitubercular Agents
  • HIV Infections
  • HIV-1
  • Tuberculosis

abstract

  • Overall, earlier ART did not reduce the rate of new AIDS-defining illness and death, as compared with later ART. In persons with CD4+ T-cell counts of less than 50 per cubic millimeter, earlier ART was associated with a lower rate of new AIDS-defining illnesses and death. (Funded by the National Institutes of Health and others; ACTG A5221 ClinicalTrials.gov number, NCT00108862.).

publication date

  • October 20, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3327101

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1013607

PubMed ID

  • 22010914

Additional Document Info

start page

  • 1482

end page

  • 91

volume

  • 365

number

  • 16